Lifileucel-induced in vitro IFNγ response to antibody coated beads (anti-CD3, anti-CD28, anti-CD137) and serum IP-10 levels post-treatment, correlates with reduction in tumor (Sum of Diameter of target lesions) and/or overall response. The gene discussed is TNFRSF9; the disease is neoplasm.